PROVIDING INSYGHTS
SINCE 1995
Medical Communications
Our strategic expertise;
your message delivered
Insyght’s medical content team, comprised of seasoned physicians, skilled medical writers and long-standing scientific researchers, has an unmatched understanding of the demands and parameters of the pharmaceutical industry. We harness this collective intelligence and experience and utilize it in all of our medical and scientific tactics to ensure that the strategy is delivered with the right messages to the right audience, at the right time, and in the most impactful and memorable way.
Scientific Platform Development
Literature Analysis & Publication Planning
Medical Writing & Author Support
Unbranded & Promotional Slide Decks
Clinical Trial, Therapeutic Area & Product Research
Scientific Content Development
Brand Strategy Development
Medical Education Program Design
Educational Tools & Resources
Mechanism of Action (MOA), KOL & Patient Videos
Multi-Channel Content Creation
Raising Regional Disease Awareness
The Latin American Diabetes Summit
Strategic Direction
Engaging Agenda Design
Unique Event Branding
KOL Engagement and Management
Thought Leader Identification and Management
Attendee Recruitment and Management
Scientific Presentation Development & Translation Services
Facilitation of CME Certification
Implementation and Evaluation of ROI
On-Site Event Management
Program Evaluation
Executive Report
-
This unbranded initiative represented a collaborative effort by two global pharmaceutical leaders and involved a multifunctional team across 4 countries in the region. The goals were to provide highly scientific, medical education to healthcare providers (HCPs) in Latin America to help them better understand new treatment strategies for diabetes, improve treatment inertia, and increase disease education awareness. To this end, Insyght developed a roadshow of 7 meetings in 4 countries, featuring over 35 international speakers and targeting approximately 1,000 regional physicians.
-
To help design a program that would have optimal success in the region, Insyght worked with the client team to identify and contract over 35 national and international thought leaders, and identified and coordinated with regional and local country Continuing Medical Education (CME) providers, to design a highly scientific and medically relevant event. To ensure that the program would be most engaging, Insyght also facilitated the design of multiple scientific presentations, medical lectures and interactive workshops that were compliant with country and regional specific guidelines and requirements, and ensured full alignment across stakeholders via regional, country and KOL-specific web and teleconferences.
-
The result was the successful education of over 930 physicians across the region, including endocrinologists, internists and primary care physicians, on critical issues pertaining to the identification, treatment and management of type 2 diabetes mellitus. As Insyght was able to secure accreditation for the program, and the initiative also strengthened partnerships with local and regional CME providers, the summit solidified Insyght’s role as this client’s strategic global medical education partner and provided the foundation for future regional and disease-specific programs for the client team.
Medical Information Made Accessible
Unique Mechanism of Action (MOA) Videos to Distinguish and Promote
Strategic Direction
Market Assessment and Competitive Product Review
Medical Content Development
Storyboard and Wireframe Development
Video Narration / Script Development
Implementation and Evaluation of ROI
High Definition Video Production
Integration with Speaker Materials and Product Websites
-
When a major east-coast pharmaceutical company launched a new smoking cessation product with a novel central mechanism of action (MOA), Insyght supported this launch at multiple levels, including the creation of an awardwinning video to illustrate the unique properties of the product. As this new, nonnicotine prescription medicine was entering a fairly competitive market in which nicotine replacement therapies and other drugs had a long-standing foothold, positioning the product in a distinct manner was critical to its market success.
-
After in-depth discussions with the client’s medical team members, participation at and analysis of discussions during advisory board meetings and review of product information, Insyght developed story boards, wireframes, and an associated script, and facilitated the medical, legal, regulatory and final review of the video.
-
The result was the design of an award-winning, novel, high definition video that showcased the product’s mechanism of action. The video was developed so that it could be used as a stand-alone video (e.g., positioned on the product website) or integrated as part of various speaker presentations that could be tailored per audience type / experience level.
Leveraging Cross-Functional Lessons Learned
Comprehensive Product Lifecycle Analysis
Strategic Direction
Development of Standard Operating Procedure (SOP) Recommendations
Program Content Development
Engaging Agenda Design
Design and Organization of Session Presentations
Implementation and Evaluation of ROI
Facilitation of Multiple Lessons Learned
Workshops Across Two Distinct Events
Executive Report
-
Following the FDA’s decision to not approve a new investigational drug, Insyght was commissioned to conduct a cross-functional analysis of our client’s processes and procedures in place throughout the product lifecycle in order to establish a clear set of standard operating procedures (SOPs) and to improve the overall effectiveness of the R&D program.
-
Insyght designed and facilitated an intensive Lessons Learned meeting series with more than 50 individuals involved in all aspects of the molecule’s lifecycle. Participants included members of the Research and Development, Clinical Development, Medical Sciences, Product Development, Marketing, Emerging Brands, Manufacturing, Medical Affairs, Legal, Regulatory, IT, Finance and Corporate Affairs teams. The meeting series involved group discussions and intensive workshop sessions to explore key accomplishments, perceived challenges, clarity of processes, corporate governance and general communication across clinical development, the Biologics License Application (BLA) process, advisory committee activities, and launch planning stages to identify functional group-specific and global issues.
-
Insyght’s assistance helped distill important issues specific to functional groups, as well as the broader organization, and led to several critical operational changes, including implementation of new cross-functional SOPs, design of more rigorous staff training and evaluation criteria, creation of improved risk assessment tools and integration of a new FDA scenario planning program. These initiatives were each designed to improve operating efficiency and crossfunctional effectiveness in order to ultimately improve the development of future biologics.